Header Logo

Connection

David Smelson to Humans

Back to Details
This is a "connection" page, showing publications David Smelson has written about Humans.
David Smelson
Connection Strength
1.484
Humans
  1. Helm A, Shaffer P, Gonzalez G, Li W, Olmstead T, Berlowitz D, Epstein E, Smelson D. Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial. Contemp Clin Trials. 2024 Oct; 145:107668.
    View in: PubMed
    Score: 0.036
  2. Helm AF, Andre MA, Shaffer PM, Bruzios KE, Marcus S, Harter J, Smelson D. Multicomponent Co-Occurring Disorders Treatment and Wraparound Services for Individuals Experiencing Chronic Homelessness. Community Ment Health J. 2024 Aug; 60(6):1203-1213.
    View in: PubMed
    Score: 0.035
  3. Blonigen DM, Macia KS, Cucciare MA, Smelson D. For whom are treatments for criminal recidivism effective? Moderator effects from a randomized controlled trial of justice-involved veterans. J Consult Clin Psychol. 2024 Feb; 92(2):118-128.
    View in: PubMed
    Score: 0.034
  4. Blonigen DM, Shaffer PM, Baldwin N, Smelson D. Disentangling the relationship between posttraumatic stress disorder, criminogenic risk, and criminal history among veterans. Law Hum Behav. 2023 10; 47(5):579-590.
    View in: PubMed
    Score: 0.034
  5. Gaba A, Helm A, Shaffer PM, Pridgen B, Drawbridge D, Smelson D. Community reentry: Racial/ethnic differences in unmet needs among adults with co-occurring opioid use and mental health disorder. Int J Law Psychiatry. 2023 Nov-Dec; 91:101924.
    View in: PubMed
    Score: 0.033
  6. Blonigen D, Hyde J, McInnes DK, Yoon J, Byrne T, Ngo T, Smelson D. Integrating data analytics, peer support, and whole health coaching to improve the health outcomes of homeless veterans: Study protocol for an effectiveness-implementation trial. Contemp Clin Trials. 2023 02; 125:107065.
    View in: PubMed
    Score: 0.032
  7. Kim B, Petrakis BA, Sliwinski SK, McInnes DK, Gifford AL, Smelson DA. Staff and Veteran Perspectives on Residential Treatment Programs' Responses to COVID-19: A Qualitative Study Guided by the WHO's After Action Review Framework. Community Ment Health J. 2023 04; 59(3):600-608.
    View in: PubMed
    Score: 0.032
  8. Bruzios KE, Shaffer PM, Byrne T, Pinals DA, Trojano M, Pressman K, Smelson D. Examining Perceived Coercion in Drug Treatment Courts. Int J Offender Ther Comp Criminol. 2023 01; 67(1):53-65.
    View in: PubMed
    Score: 0.031
  9. Gaba A, Shaffer PM, Andre M, Pinals DA, Drawbridge D, Smelson D. Racial and ethnic differences in behavioral health, criminal legal system involvement, and service needs among mental health court participants: Implications for service delivery. Psychol Serv. 2022 Nov; 19(4):637-647.
    View in: PubMed
    Score: 0.031
  10. Kim B, Petrakis BA, McInnes DK, Gifford AL, Sliwinski SK, Smelson DA. Applying after action review to examine residential treatment programs' responses to COVID-19. Int J Health Plann Manage. 2022 Jul; 37(4):2461-2467.
    View in: PubMed
    Score: 0.030
  11. Blonigen DM, Cucciare MA, Byrne T, Shaffer PM, Giordano B, Smith JS, Timko C, Rosenthal J, Smelson D. A randomized controlled trial of moral reconation therapy to reduce risk for criminal recidivism among justice-involved adults in mental health residential treatment. J Consult Clin Psychol. 2022 May; 90(5):413-426.
    View in: PubMed
    Score: 0.030
  12. Smelson DA, Yakovchenko V, Byrne T, McCullough MB, Smith JL, Bruzios KE, Gabrielian S. Testing implementation facilitation for uptake of an evidence-based psychosocial intervention in VA homeless programs: A hybrid type III trial. PLoS One. 2022; 17(3):e0265396.
    View in: PubMed
    Score: 0.030
  13. Blonigen DM, Smith JS, Javier S, Cucciare MA, Timko C, Nevedal AL, Filice N, Rosenthal J, Smelson D. Implementation Potential of Moral Reconation Therapy for Criminal Recidivism in Mental Health Residential Programs. Psychiatr Serv. 2022 08 01; 73(8):856-863.
    View in: PubMed
    Score: 0.030
  14. Macia KS, Blonigen DM, Shaffer PM, Cloitre M, Smelson DA. Trauma-related differences in socio-emotional functioning predict housing and employment outcomes in homeless veterans. Soc Sci Med. 2021 07; 281:114096.
    View in: PubMed
    Score: 0.029
  15. Shaffer PM, Rodriguez CP, Gaba A, Byrne T, Casey SC, Harter J, Smelson D. Engaging vulnerable populations in drug treatment court: Six month outcomes from a co-occurring disorder wraparound intervention. Int J Law Psychiatry. 2021 May-Jun; 76:101700.
    View in: PubMed
    Score: 0.028
  16. Pinals DA, Gaba A, Shaffer PM, Andre MA, Smelson DA. Risk-need-responsivity and its application in behavioral health settings: A feasibility study of a treatment planning support tool. Behav Sci Law. 2021 Feb; 39(1):44-64.
    View in: PubMed
    Score: 0.028
  17. Smelson DA, Gaba A, Pressman K, Clary KM, Shaffer PM, Pinals DA. Embedding a Co-occurring Disorders Rehabilitation Intervention in Veterans Courts: A Pilot Study with Male Veterans. Community Ment Health J. 2020 07; 56(5):970-977.
    View in: PubMed
    Score: 0.026
  18. Pinals DA, Gaba A, Clary KM, Barber J, Reiss J, Smelson D. Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders. Psychiatr Serv. 2019 11 01; 70(11):1044-1048.
    View in: PubMed
    Score: 0.025
  19. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. Public Perceptions of Recovery Prospects and Peer Style (Support and Confrontation) in Services for Serious Mental Illness Versus Substance Use Disorder. J Dual Diagn. 2019 Oct-Dec; 15(4):226-232.
    View in: PubMed
    Score: 0.025
  20. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. How does the public understand recovery from severe mental illness versus substance use disorder? Psychiatr Rehabil J. 2019 Dec; 42(4):341-349.
    View in: PubMed
    Score: 0.025
  21. Smelson DA, Perez CK, Farquhar I, Byrne T, Colegrove A. Permanent Supportive Housing and Specialized Co-Occurring Disorders Wraparound Services for Homeless Individuals. J Dual Diagn. 2018 Oct-Dec; 14(4):247-256.
    View in: PubMed
    Score: 0.024
  22. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. Am J Manag Care. 2018 11; 24(11):536-540.
    View in: PubMed
    Score: 0.024
  23. Smelson DA, Chinman M, Hannah G, Byrne T, McCarthy S. An evidence-based co-occurring disorder intervention in VA homeless programs: outcomes from a hybrid III trial. BMC Health Serv Res. 2018 May 05; 18(1):332.
    View in: PubMed
    Score: 0.023
  24. McIlvane WJ, Kledaras JB, Gerard CJ, Wilde L, Smelson D. Algorithmic analysis of relational learning processes in instructional technology: Some implications for basic, translational, and applied research. Behav Processes. 2018 Jul; 152:18-25.
    View in: PubMed
    Score: 0.023
  25. Blonigen DM, Cucciare MA, Timko C, Smith JS, Harnish A, Kemp L, Rosenthal J, Smelson D. Study protocol: a hybrid effectiveness-implementation trial of Moral Reconation Therapy in the US Veterans Health Administration. BMC Health Serv Res. 2018 03 07; 18(1):164.
    View in: PubMed
    Score: 0.023
  26. Smelson D, Farquhar I, Fisher W, Pressman K, Pinals DA, Samek B, Duffy MK, Sawh L. Integrating a Co-occurring Disorders Intervention in Drug Courts: An Open Pilot Trial. Community Ment Health J. 2019 02; 55(2):222-231.
    View in: PubMed
    Score: 0.023
  27. Trojano ML, Christopher PP, Pinals DA, Harnish A, Smelson D. Perceptions of voluntary consent among jail diverted veterans with co-occurring disorders. Behav Sci Law. 2017 Sep; 35(5-6):408-417.
    View in: PubMed
    Score: 0.022
  28. Simmons MM, Gabrielian S, Byrne T, McCullough MB, Smith JL, Taylor TJ, O'Toole TP, Kane V, Yakovchenko V, McInnes DK, Smelson DA. A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs. Implement Sci. 2017 04 04; 12(1):46.
    View in: PubMed
    Score: 0.021
  29. Chinman M, McCarthy S, Hannah G, Byrne TH, Smelson DA. Using Getting To Outcomes to facilitate the use of an evidence-based practice in VA homeless programs: a cluster-randomized trial of an implementation support strategy. Implement Sci. 2017 03 09; 12(1):34.
    View in: PubMed
    Score: 0.021
  30. Corrigan P, Schomerus G, Smelson D. Are some of the stigmas of addictions culturally sanctioned? Br J Psychiatry. 2017 03; 210(3):180-181.
    View in: PubMed
    Score: 0.021
  31. Corrigan PW, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-Willis K, Qin S, Smelson D. Developing a research agenda for reducing the stigma of addictions, part II: Lessons from the mental health stigma literature. Am J Addict. 2017 Jan; 26(1):67-74.
    View in: PubMed
    Score: 0.021
  32. Corrigan P, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-Willis K, Qin S, Smelson D. Developing a research agenda for understanding the stigma of addictions Part I: Lessons from the Mental Health Stigma Literature. Am J Addict. 2017 Jan; 26(1):59-66.
    View in: PubMed
    Score: 0.021
  33. Harnish A, Corrigan P, Byrne T, Pinals DA, Rodrigues S, Smelson D. Substance Use and Mental Health Stigma in Veterans With Co-Occurring Disorders. J Dual Diagn. 2016 Jul-Dec; 12(3-4):238-243.
    View in: PubMed
    Score: 0.021
  34. Smelson DA, Zaykowski H, Guevermont N, Siegfriedt J, Sawh L, Modzelewski D, Tsemberis S, Kane V. Integrating Permanent Supportive Housing and Co-Occurring Disorders Treatment for Individuals Who Are Homeless. J Dual Diagn. 2016 Apr-Jun; 12(2):193-201.
    View in: PubMed
    Score: 0.020
  35. Smelson DA, Chinman M, McCarthy S, Hannah G, Sawh L, Glickman M. A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs. Implement Sci. 2015 May 28; 10:79.
    View in: PubMed
    Score: 0.019
  36. McInnes DK, Sawh L, Petrakis BA, Rao S, Shimada SL, Eyrich-Garg KM, Gifford AL, Anaya HD, Smelson DA. The potential for health-related uses of mobile phones and internet with homeless veterans: results from a multisite survey. Telemed J E Health. 2014 Sep; 20(9):801-9.
    View in: PubMed
    Score: 0.018
  37. Smelson DA, Kline A, Kuhn J, Rodrigues S, O'Connor K, Fisher W, Sawh L, Kane V. A wraparound treatment engagement intervention for homeless veterans with co-occurring disorders. Psychol Serv. 2013 May; 10(2):161-7.
    View in: PubMed
    Score: 0.016
  38. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict. 2012 Sep-Oct; 21(5):411-5.
    View in: PubMed
    Score: 0.016
  39. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of Qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101.
    View in: PubMed
    Score: 0.015
  40. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J. 2012 Apr; 48(2):127-32.
    View in: PubMed
    Score: 0.014
  41. Fortuna JL, Smelson DA. The phenomenon of drug craving. J Psychoactive Drugs. 2008 Sep; 40(3):255-61.
    View in: PubMed
    Score: 0.012
  42. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008; 22(11):903-16.
    View in: PubMed
    Score: 0.011
  43. Smelson DA, Tunis SL, Nyhuis AW, Faries DE, Kinon BJ, Ascher-Svanum H. Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use. J Clin Psychopharmacol. 2006 Dec; 26(6):666-7.
    View in: PubMed
    Score: 0.010
  44. Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12.
    View in: PubMed
    Score: 0.010
  45. Bowdring MA, Macia KS, Shaffer PM, Smelson D, Blonigen DM. Criminogenic Needs and?Legal Problem Severity Among Legal System Involved Veterans. Mil Med. 2024 Jul 03; 189(7-8):e1544-e1551.
    View in: PubMed
    Score: 0.009
  46. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
    View in: PubMed
    Score: 0.009
  47. Carreiro S, Ramanand P, Taylor M, Leach R, Stapp J, Sherestha S, Smelson D, Indic P. Evaluation of a digital tool for detecting stress and craving in SUD recovery: An observational trial of accuracy and engagement. Drug Alcohol Depend. 2024 Aug 01; 261:111353.
    View in: PubMed
    Score: 0.009
  48. Swong S, Nicholson A, Smelson D, Rogers ES, El-Shahawy O, Sherman SE. The effectiveness of a telephone smoking cessation program in mental health clinic patients by level of mental well-being and functioning: a secondary data analysis of a randomized clinical trial. BMC Public Health. 2023 11 07; 23(1):2190.
    View in: PubMed
    Score: 0.008
  49. Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003 Oct; 326(4):223-30.
    View in: PubMed
    Score: 0.008
  50. Suzuki J, Martin B, Loguidice F, Smelson D, Liebschutz JM, Schnipper JL, Weiss RD. A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. J Addict Med. 2023 Sep-Oct 01; 17(5):604-607.
    View in: PubMed
    Score: 0.008
  51. Pivovarova E, Taxman FS, Boland AK, Smelson DA, Lemon SC, Friedmann PD. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. J Subst Use Addict Treat. 2023 04; 147:208950.
    View in: PubMed
    Score: 0.008
  52. Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J Subst Abuse Treat. 2003 Jan; 24(1):75-9.
    View in: PubMed
    Score: 0.008
  53. Blonigen D, Smelson D, Smith J, Baldwin N, McInnes DK, Raikov I, Weber J, Hyde J. Peer support and whole health coaching to address the healthcare needs of homeless veterans: a pilot study. BMC Prim Care. 2022 12 19; 23(1):331.
    View in: PubMed
    Score: 0.008
  54. Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6.
    View in: PubMed
    Score: 0.008
  55. Timko C, Vest N, Cucciare MA, Smelson D, Blonigen D. Substance use and criminogenic thinking: Longitudinal latent class analysis of veterans with criminal histories. J Subst Abuse Treat. 2022 12; 143:108893.
    View in: PubMed
    Score: 0.008
  56. Hayes D, Henderson C, Bakolis I, Lawrence V, Elliott RA, Ronaldson A, Richards G, Repper J, Bates P, Brewin J, Meddings S, Winship G, Bishop S, Emsley R, Elton D, McNaughton R, Whitley R, Smelson D, Stepanian K, McPhilbin M, Dunnett D, Hunter-Brown H, Yeo C, Jebara T, Slade M. Recovery Colleges Characterisation and Testing in England (RECOLLECT): rationale and protocol. BMC Psychiatry. 2022 09 24; 22(1):627.
    View in: PubMed
    Score: 0.008
  57. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
    View in: PubMed
    Score: 0.008
  58. Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatr Serv. 2022 12 01; 73(12):1320-1321.
    View in: PubMed
    Score: 0.008
  59. Smelson DA, Davis CW, Di Pano R, Johnson V, Losonczy MF, Ziedonis D. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis. 2002 Mar; 190(3):200-2.
    View in: PubMed
    Score: 0.008
  60. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Subst Abus. 2022; 43(1):556-563.
    View in: PubMed
    Score: 0.007
  61. Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse. 2001 May; 27(2):391-7.
    View in: PubMed
    Score: 0.007
  62. Holzhauer CG, Epstein EE, Smelson DA, Mattocks K. Targeting women veteran's stress-induced drinking with cognitive reappraisal: Mechanisms and moderators of change. J Subst Abuse Treat. 2021 11; 130:108408.
    View in: PubMed
    Score: 0.007
  63. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2021 04 01; 15(2):143-149.
    View in: PubMed
    Score: 0.007
  64. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care. 2021 04 01; 59(Suppl 2):S165-S169.
    View in: PubMed
    Score: 0.007
  65. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. J Subst Abuse Treat. 2021 10; 129:108353.
    View in: PubMed
    Score: 0.007
  66. Blonigen DM, Shaffer PM, Smith JS, Cucciare MA, Timko C, Smelson D, Blue-Howells J, Clark S, Rosenthal J. Recidivism Treatment for Justice-Involved Veterans: Evaluating Adoption and Sustainment of Moral Reconation Therapy in the US Veterans Health Administration. Adm Policy Ment Health. 2021 11; 48(6):992-1005.
    View in: PubMed
    Score: 0.007
  67. Boyer EW, Levy S, Smelson D, Vargas S, Casey A. The Clinical Assessment of Vaping Exposure. J Addict Med. 2020 12; 14(6):446-450.
    View in: PubMed
    Score: 0.007
  68. Byrne T, Baggett T, Land T, Bernson D, Hood ME, Kennedy-Perez C, Monterrey R, Smelson D, Dones M, Bharel M. A classification model of homelessness using integrated administrative data: Implications for targeting interventions to improve the housing status, health and well-being of a highly vulnerable population. PLoS One. 2020; 15(8):e0237905.
    View in: PubMed
    Score: 0.007
  69. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. J Gen Intern Med. 2020 09; 35(9):2529-2536.
    View in: PubMed
    Score: 0.007
  70. Ellison ML, Schutt RK, Yuan LH, Mitchell-Miland C, Glickman ME, McCarthy S, Smelson D, Schultz MR, Chinman M. Impact of Peer Specialist Services on Residential Stability and Behavioral Health Status Among Formerly Homeless Veterans With Cooccurring Mental Health and Substance Use Conditions. Med Care. 2020 04; 58(4):307-313.
    View in: PubMed
    Score: 0.007
  71. Carreiro S, Chintha KK, Shrestha S, Chapman B, Smelson D, Indic P. Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study. Drug Alcohol Depend. 2020 04 01; 209:107929.
    View in: PubMed
    Score: 0.007
  72. Blonigen DM, Macia KS, Smelson D, Timko C. Criminal recidivism among justice-involved veterans following substance use disorder residential treatment. Addict Behav. 2020 07; 106:106357.
    View in: PubMed
    Score: 0.007
  73. Timko C, Taylor E, Nash A, Blonigen D, Smelson D, Tsai J, Finlay AK. National Survey of Legal Clinics Housed by the Department of Veterans Affairs to Inform Partnerships with Health and Community Services. J Health Care Poor Underserved. 2020; 31(3):1440-1456.
    View in: PubMed
    Score: 0.006
  74. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health Aff (Millwood). 2019 08; 38(8):1289-1297.
    View in: PubMed
    Score: 0.006
  75. Holzhauer CG, Byrne T, Simmons MM, Smelson D, Epstein EE. Profiles of Clinical Need Among Homeless Individuals with Dual Diagnoses. Community Ment Health J. 2019 11; 55(8):1305-1312.
    View in: PubMed
    Score: 0.006
  76. Hanna J, Kubiak S, Pasman E, Gaba A, Andre M, Smelson D, Pinals DA. Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative. J Subst Abuse Treat. 2020 01; 108:104-114.
    View in: PubMed
    Score: 0.006
  77. Smelson DA, Roy A, Santana S, Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse. 1999 May; 25(2):377-81.
    View in: PubMed
    Score: 0.006
  78. Corrigan PW, Larson JE, Smelson D, Andra M. Recovery, peer support and confrontation in services for people with mental illness and/or substance use disorder. Br J Psychiatry. 2019 03; 214(3):130-132.
    View in: PubMed
    Score: 0.006
  79. Smelson DA, McGee-Caulfield E, Bergstein P, Engelhart C. Initial validation of the Voris Cocaine Craving Scale: a preliminary report. J Clin Psychol. 1999 Jan; 55(1):135-9.
    View in: PubMed
    Score: 0.006
  80. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. J Subst Abuse Treat. 2018 12; 95:43-47.
    View in: PubMed
    Score: 0.006
  81. Rogers ES, Gillespie C, Smelson D, Sherman SE. A Qualitative Evaluation of Mental Health Clinic Staff Perceptions of Barriers and Facilitators to Treating Tobacco Use. Nicotine Tob Res. 2018 09 04; 20(10):1223-1230.
    View in: PubMed
    Score: 0.006
  82. Smelson DA, Roy M, Roy A, Santana S. Electroretinogram in withdrawn cocaine-dependent subjects. Relationship to cue-elicited craving. Br J Psychiatry. 1998 Jun; 172:537-9.
    View in: PubMed
    Score: 0.006
  83. Roy A, Roy M, Smelson DA. Risperidone, ERG and cocaine craving. Am J Addict. 1998; 7(1):90.
    View in: PubMed
    Score: 0.006
  84. DiGirolamo GJ, Gonzalez G, Smelson D, Guevremont N, Andre MI, Patnaik PO, Zaniewski ZR. Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder. J Dual Diagn. 2017 Oct-Dec; 13(4):298-304.
    View in: PubMed
    Score: 0.006
  85. Smelson DA, Roy A, Roy M. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients. Can J Psychiatry. 1997 Nov; 42(9):984.
    View in: PubMed
    Score: 0.006
  86. Simmons MM, Fincke BG, Drainoni ML, Kim B, Byrne T, Smelson D, Casey K, Ellison ML, Visher C, Blue-Howells J, McInnes DK. A two-state comparative implementation of peer-support intervention to link veterans to health-related services after incarceration: a study protocol. BMC Health Serv Res. 2017 Sep 12; 17(1):647.
    View in: PubMed
    Score: 0.006
  87. Smelson DA, Kordon ME, Rudolph B. Evaluating the diagnostic interview: obstacles and future directions. J Clin Psychol. 1997 Aug; 53(5):497-505.
    View in: PubMed
    Score: 0.005
  88. Desai P, Roy M, Roy A, Brown S, Smelson D. Impaired color vision in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Aug; 54(8):696-9.
    View in: PubMed
    Score: 0.005
  89. Blonigen DM, Rodriguez AL, Manfredi L, Nevedal A, Rosenthal J, McGuire JF, Smelson D, Timko C. Cognitive-behavioral treatments for criminogenic thinking: Barriers and facilitators to implementation within the Veterans Health Administration. Psychol Serv. 2018 Feb; 15(1):87-97.
    View in: PubMed
    Score: 0.005
  90. Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. Can J Psychiatry. 1997 May; 42(4):431.
    View in: PubMed
    Score: 0.005
  91. Finlay AK, Stimmel M, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I, Smelson D, Harris AH, Frayne SM, Bowe T, Timko C. Use of Veterans Health Administration Mental Health and Substance Use Disorder Treatment After Exiting Prison: The Health Care for Reentry Veterans Program. Adm Policy Ment Health. 2017 Mar; 44(2):177-187.
    View in: PubMed
    Score: 0.005
  92. Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Feb; 54(2):153-6.
    View in: PubMed
    Score: 0.005
  93. Ellison ML, Schutt RK, Glickman ME, Schultz MR, Chinman M, Jensen K, Mitchell-Miland C, Smelson D, Eisen S. Patterns and predictors of engagement in peer support among homeless veterans with mental health conditions and substance use histories. Psychiatr Rehabil J. 2016 09; 39(3):266-273.
    View in: PubMed
    Score: 0.005
  94. Smelson DA, Roy A, Roy M. The electroretinogram and neuropsychological functioning in cocaine addicts. Can J Psychiatry. 1996 Aug; 41(6):415.
    View in: PubMed
    Score: 0.005
  95. Krebs P, Rogers E, Smelson D, Fu S, Wang B, Sherman S. Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial. J Health Psychol. 2018 07; 23(8):1119-1128.
    View in: PubMed
    Score: 0.005
  96. Okunna NC, Rodriguez-Monguio R, Smelson DA, Poudel KC, Volberg R. Gambling involvement indicative of underlying behavioral and mental health disorders. Am J Addict. 2016 Mar; 25(2):160-72.
    View in: PubMed
    Score: 0.005
  97. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6.
    View in: PubMed
    Score: 0.005
  98. Rogers ES, Smelson DA, Gillespie CC, Elbel B, Poole S, Hagedorn HJ, Kalman D, Krebs P, Fang Y, Wang B, Sherman SE. Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics: A Patient-Randomized Controlled Trial. Am J Prev Med. 2016 Apr; 50(4):518-527.
    View in: PubMed
    Score: 0.005
  99. Carreiro S, Fang H, Zhang J, Wittbold K, Weng S, Mullins R, Smelson D, Boyer EW. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use. J Med Syst. 2015 Dec; 39(12):186.
    View in: PubMed
    Score: 0.005
  100. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-253.
    View in: PubMed
    Score: 0.005
  101. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Med Care. 2015 Apr; 53(4 Suppl 1):S105-11.
    View in: PubMed
    Score: 0.005
  102. DiGirolamo GJ, Smelson D, Guevremont N. Cue-induced craving in patients with cocaine use disorder predicts cognitive control deficits toward cocaine cues. Addict Behav. 2015 Aug; 47:86-90.
    View in: PubMed
    Score: 0.005
  103. Carreiro S, Smelson D, Ranney M, Horvath KJ, Picard RW, Boudreaux ED, Hayes R, Boyer EW. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015 Mar; 11(1):73-9.
    View in: PubMed
    Score: 0.005
  104. Smelson DA. Adolescent substance abuse prevention. N J Med. 1993 Nov; 90(11):845-8.
    View in: PubMed
    Score: 0.004
  105. Rogers E, Fernandez S, Gillespie C, Smelson D, Hagedorn HJ, Elbel B, Kalman D, Axtmayer A, Kurowski K, Sherman SE. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial. Addict Sci Clin Pract. 2013 Mar 15; 8:7.
    View in: PubMed
    Score: 0.004
  106. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
    View in: PubMed
    Score: 0.004
  107. Ellison ML, Mueller L, Smelson D, Corrigan PW, Torres Stone RA, Bokhour BG, Najavits LM, Vessella JM, Drebing C. Supporting the education goals of post-9/11 veterans with self-reported PTSD symptoms: a needs assessment. Psychiatr Rehabil J. 2012; 35(3):209-17.
    View in: PubMed
    Score: 0.004
  108. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6.
    View in: PubMed
    Score: 0.003
  109. Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010 Feb; 30(1):12-24.
    View in: PubMed
    Score: 0.003
  110. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul; 37(4):727-36.
    View in: PubMed
    Score: 0.003
  111. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Womens Health Issues. 2009 Nov-Dec; 19(6):446-56.
    View in: PubMed
    Score: 0.003
  112. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res. 2008 Jul; 35(3):290-303.
    View in: PubMed
    Score: 0.003
  113. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse. 2007; 33(6):807-21.
    View in: PubMed
    Score: 0.003
  114. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7.
    View in: PubMed
    Score: 0.002
  115. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39.
    View in: PubMed
    Score: 0.002
  116. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003 Nov 26; 290(20):2693-702.
    View in: PubMed
    Score: 0.002
  117. Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31.
    View in: PubMed
    Score: 0.002
  118. Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Stern RG, Losonczy MF. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry. 1999 Jan; 60(1):41-4.
    View in: PubMed
    Score: 0.002
  119. Roy M, Roy A, Smelson D, Brown S, Weinberger L. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication. Biol Psychiatry. 1997 Oct 01; 42(7):631-3.
    View in: PubMed
    Score: 0.001
  120. Roy M, Smelson D, Roy A. Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biol Psychiatry. 1997 Jan 15; 41(2):252-3.
    View in: PubMed
    Score: 0.001
  121. Roy A, Smelson D, Lindeken S. Screening for pathological gambling among substance misusers. Br J Psychiatry. 1996 Oct; 169(4):523.
    View in: PubMed
    Score: 0.001
  122. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry. 1996 Apr; 168(4):507-11.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.